Note 9 – Commitments and Contingencies

Lease Agreements

We lease facilities under non-cancellable operating leases. Our current leases expire at various dates through 2029 and frequently include renewal provisions for varying periods of time, provisions for taxes, insurance and maintenance costs, and provisions for minimum rent increases. Minimum leases payments, including scheduled rent increases are recognized as rent expenses on a straight-line basis over the term of the lease.

The rate implicit in each lease is not readily determinable, and we therefore use our incremental borrowing rate to determine the present value of the lease payments. The weighted average incremental borrowing rate used to determine the initial value of right-of-use (“ROU”) assets and lease liabilities capitalized during the each of the six months ended June 30, 2025 and 2024 was 9.5%.

ROU assets for operating leases are periodically reduced by impairment losses. As of June 30, 2025, we have not recognized any impairment losses for our ROU assets.

We monitor for events or changes in circumstances that require a reassessment of our leases. When a reassessment results in the remeasurement of a lease liability, a corresponding adjustment is made to the carrying amount of the corresponding ROU asset unless doing so would reduce the carrying amount of the ROU asset to an amount less than zero. In that case, the amount of the adjustment that would result in a negative ROU asset balance is recorded in profit or loss.

In May 2024, we entered into a lease agreement for a 5,183 square-foot manufacturing facility and administrative offices located in Fremont, California. The lease term is five years and three months, with monthly base rent of approximately $11,000, subject to annual increases of 3.5%. In addition to base rent, we are responsible for our proportionate share of common area operating expenses. We previously leased a 10,635 square - foot manufacturing facility located in Newark, California, which had a monthly rent of approximately $19,000. We vacated the Newark facility in December 2024.

In June 2023, we entered into a lease agreement for a 1,560 square - foot office space in Irvine, California for approximately $4,000 per month for a term commencing June 2023 and ending May 2024. The term of this lease has been extended through December 31, 2025 for the same rental amount. Our Irvine, California office is used for executive offices, sales, finance and administration.

In April 2024, we entered into a lease agreement for a 2,480 square - foot office space in Bellevue, Washington, at a monthly rent of approximately $9,000. This lease term begins in July 2024 and ends in October 2027. In March 2025, we entered into a sublease agreement with a third party for the same office space at a monthly rate of approximately $10,000. In accordance with the terms of our lease agreement, a portion of the premium of the sublease rent over our base rent is shared with the landlord. The sublease term began in March 2025 and also ends in October 2027.

We lease a 14,476 square-foot manufacturing facility and administrative office in Shenzhen, China. In May 2024, we renewed this lease for the period June 2024 through May 2026 for approximately $8,000 per month. In May 2024, we also leased an additional 7,287 square-foot facility in Shenzhen, China for a two - year term for approximately $3,000 per month. In June 2025, we modified the lease on this additional facility, reducing the footprint to 1,292 square - feet, reducing the monthly rent to approximately $1,000, and extending the term to June 2027.

We lease an approximately 9,800 square-foot manufacturing facility and administrative offices in Irvine, Scotland for approximately $5,000 per month. This lease term ends February 2028.

We use a 10,786 square - foot manufacturing facility and administrative offices in Barnsley, England subject to a temporary premise license agreement for the period from January 2025 to September 2025 for approximately $11,000 per month.

We lease a 3,000 square-foot logistics and distribution facility in Hong Kong for approximately $2,000 per month. This lease term ends April 2027.

We lease a 500 square-foot sales office in Tokyo, Japan for approximately $1,000 per month. This lease term ends November 2026.

We previously leased a 275 square - foot engineering and administrative office in Singapore for approximately $1,000 per month through June 2025.

As of June 30, 2025, we had current and long-term lease liabilities of $353,000 and $641,000, respectively, and right-of-use assets of $931,000. As of December 31, 2024, we had current and long-term lease liabilities of $352,000 and $777,000, respectively, and right of use assets of $1,064,000. Future imputed interest as of June 30, 2025 totaled $156,000 (weighted average discount rate of 9.1)%; and future imputed interest as of December 31, 2024 totaled $199,000 (weighted average discount rate of 8.9)%. The weighted average remaining lease term of the Company’s leases as of June 30, 2025 is 2.0 years; and as of December 31, 2024 was 2.2 years.

Future minimum lease payments under non-cancellable operating leases that have remaining non-cancellable lease terms in excess of one year are as follows:

​

​

During the three months ended June 30, 2025, we incurred approximately $136,000 in operating lease costs, of which $76,000 is included in cost of revenue and $60,000 is included in operating expenses in our condensed consolidated statements of operations. During the three months ended June 30, 2024, we incurred approximately $156,000 in operating lease costs, of which $86,000 are included in cost of revenue and $71,000 are included in operating expenses in our condensed consolidated statements of operations.

During the six months ended June 30, 2025, we incurred approximately $269,000 in operating lease costs. Operating lease costs of $150,000 is included in cost of revenue, and $119,000 is included in operating expenses in our condensed consolidated statements of operations. During the six months ended June 30, 2024, we incurred approximately $280,000 in operating lease costs. Operating lease costs of $155,000 are included in cost of revenue, and $125,000 are included in operating expenses in our condensed consolidated statements of operations.

Litigation

We are not party to any legal proceedings as of June 30, 2025. We are occasionally involved in legal proceedings in the ordinary course of business, including actions against us which assert or may assert claims or seek to impose fines and penalties in substantial amounts. Related legal defense costs are expensed as incurred.

Warranties

We establish reserves for future product warranty costs that are expected to be incurred pursuant to specific warranty provisions with our customers. We generally warrant our products against defects for one year from date of shipment, with certain exceptions in which the warranty period can extend to more than one year based on contractual agreements. Our warranty reserves are established at the time of sale and updated throughout the warranty period based upon numerous factors including historical warranty return rates and expenses over various warranty periods. Historically, our warranty returns have not been material.

Intellectual Property Indemnities

We indemnify certain customers and our contract manufacturers against liability arising from third-party claims of intellectual property rights infringement related to our products. These indemnities appear in development and supply agreements with our customers as well as manufacturing service agreements with our contract manufacturers, are not limited in amount or duration and generally survive the expiration of the contract. Given that the amount of any potential liabilities related to such indemnities cannot be determined until an infringement claim has been made, we are unable to determine the maximum amount of losses that we could incur related to such indemnifications.

Director and Officer Indemnities and Contractual Guarantees

Pursuant to our bylaws, we will indemnify our directors and executive officers to the fullest extent permitted by Nevada law, without limitation as to amount or duration, in the event of any actual or threatened lawsuit or proceeding. Certain costs incurred in connection with such indemnifications may be recovered under certain circumstances under various insurance policies. Given that the amount of any potential liabilities related to such indemnities cannot be determined until a lawsuit or proceeding has been threatened or filed, we are unable to determine the maximum amount of losses that we could incur relating to such indemnities.

We have entered into an employment agreement with Steven N. Bronson, our Chairman of the Board, President and Chief Executive Officer. This agreement contains certain severance and change in control obligations. Under the agreement, if Mr. Bronson’s employment is terminated due to his death or disability (as such terms are defined in the agreement), Mr. Bronson or his beneficiaries will be entitled to receive: (i) his base compensation to the end of the monthly pay period immediately following the date of termination; (ii) accrued bonus payments; and (iii) immediate and full vesting of all unvested equity and/or options issued by the Company. If Mr. Bronson’s employment is terminated by him for good reason (as such term is defined in the agreement), or by us without cause, then Mr. Bronson will be entitled to receive: (i) his base compensation to the date of termination; (ii) a severance payment equal to twelve months of his base compensation; (iii) any earned bonus compensation; (iv) employee benefits for twelve months following the date of termination; (v) any vested company match 401(k) or other retirement contribution; and (vi) immediate and full vesting of all unvested equity and/or options issued by the Company.

In the event of a change in control of the Company (as such term is defined in the agreement), Mr. Bronson is entitled to receive: (i) a change in control payment in an amount equal to twelve months of his base compensation, payable as of the date the change in control occurs; and (ii) immediate and full vesting of all unvested equity and/or options issued by the Company.

Guarantees and Indemnities

In the normal course of business, we are occasionally required to undertake indemnification for which we may be required to make future payments under specific circumstances. We review our exposure under such obligations no less than annually, or more frequently as required. The amount of any potential liabilities related to such obligations cannot be accurately determined until a formal claim is filed. Historically, any such amounts that become payable have not had a material negative effect on our business, financial condition or results of operations. We maintain general and product liability insurance which may provide a source of recovery to us in the event of an indemnification claim.